Cotellic 20 mg – DIN 02452340
Cotellic is Cobimetinib Fumarate 20 mg (tablet), sold in Canada. It is used for melanoma. It is supplied by Hoffmann-LA Roche Limited. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Cobimetinib Fumarate 20 mg
- Brand
- Cotellic
- Strength
- 20 mg
- Used for
- Melanoma
- Form
- Tablet
- Manufacturer
- Hoffmann-LA Roche Limited
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02452340
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Cobimetinib used for?
Cobimetinib is used for melanoma.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Unresectable or Metastatic Melanoma
COTELLIC ® is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, in combination with vemurafenib.
Histiocytic Neoplasms
COTELLIC®, as a single agent, is indicated for the treatment of adult patients with histiocytic neoplasms.
From the FDA-approved label on DailyMed (published Sep 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02452340.
- It names Cotellic, Cobimetinib Fumarate 20 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Cotellic by Hoffmann-LA Roche Limited.
In Canada: prescription only.
Ingredients
Active: Cobimetinib (Cobimetinib Fumarate)